{
    "Trade/Device Name(s)": [
        "ETEST Delafloxacin",
        "ETEST DFX",
        "ETEST Delafloxacin (DFX) (0.002-32 \u03bcg/mL)"
    ],
    "Submitter Information": "bioMerieux SA",
    "510(k) Number": "K192738",
    "Predicate Device Reference 510(k) Number(s)": [
        "K180936"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY"
    ],
    "Summary Letter Date": "September 26, 2019",
    "Summary Letter Received Date": "September 27, 2019",
    "Submission Date": "September 26, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Delafloxacin"
    ],
    "Specimen Type(s)": [
        "Gram-negative aerobic bacteria",
        "Gram-positive aerobic bacteria",
        "fastidious bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ETEST strip",
        "optional inoculator",
        "ETEST strip applicator",
        "Inoculator RETRO C80",
        "Vacuum Pen NEMA C88"
    ],
    "Method(s)/Technology(ies)": [
        "Manual antimicrobial susceptibility testing",
        "Agar diffusion antibiotic gradient"
    ],
    "Methodologies": [
        "Minimum Inhibitory Concentration determination"
    ],
    "Submission Type(s)": [
        "Strip test"
    ],
    "Document Summary": "FDA 510(k) summary for ETEST Delafloxacin manual antimicrobial susceptibility strip for MIC determination of aerobic Gram-positive and Gram-negative bacteria",
    "Indications for Use Summary": "Manual, quantitative determination of antimicrobial susceptibility (MIC) of delafloxacin against non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria using agar media",
    "fda_folder": "Microbiology"
}